The Great Ozempic Experiment

In Winooski, Vermont, one man's experience highlights an unexpected chapter in the GLP-1 story: using the popular class of medications to manage symptoms of long Covid. As researchers continue to study the wide-ranging effects of drugs like Ozempic and Wegovy beyond weight loss and diabetes, patients living with long Covid are exploring whether these medications might offer relief. This portrait for The New York Times documents his experience in Winooski, part of a broader look at how GLP-1s are being used—and studied—for conditions their makers never anticipated.